Brain, Vol. 116, No. 5, 1201-1222, 1993
© 1993 Guarantors of Brain
research-article |
Neurochemical substrates of rigidity and chorea in Huntington's disease
Neurochemistry Laboratory, Neurology Service, Massachusetts General Hospital and Harvard Medical School Boston, MA, USA
Correspondence to:
Correspondence to Dr E Storey, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia 3052
Huntington's disease is a progressive degenerative neurological disorder which produces a characteristic movement disorder termed chorea. Although chorea is associated with dysfunction of the basal ganglia, the underlying mechanisms by which dyskinesias such as chorea are produced, are poorly understood. Recent studies in primates have led to experimental models of chorea with postulated involvement of specific neural pathways. In the present study we attempted to determine the validity of the experimental models by measuring concentrations of 
aminobutyric acid (GABA), glutamate, substance P and met-enkephalin in the basal ganglia of Huntington's disease patients who manifested either chorea or rigidity/bradykinesia within 6 months of death. We also characterized changes in the Huntington's disease patients according to pathological grade, since this may be a confounding factor. We analysed post-mortern brain tissue from 12 controls, and 11 grade 3 and 12 grade 4 Huntington's disease patients. The grade 3 and 4 cases consisted of eight adult-onset choreic, nine adult-onset rigid and six juvenile-onset rigid patients. We also analysed the putamen and globus pallidus from 11 grade 2 adult onset choreic Huntington's disease patients. A model of chorea based on experimental studies in primates proposes that a loss of striatal GABAergic inhibitory projections to the globus pallidus externa leads to increased activity of the inhibitory globus pallidus externa GABAergic neurons which project to the subthalamic nucleus. It is believed that the loss of GABAergic inputs to the globus pallidus externa precedes a loss of GABAergic input to the globus pallidus interna, which occurs later in the disease and is associated with the development of rigidity and bradykinesia. In the choreic Huntington's disease patients whom we studied, there was a greater loss of GABA in the globus pallidus externa than in the globus pallidus interna, and the globus pallidus interna: globus pallidus externa GABA ratio was significantly increased compared with rigid patients. There were also increases in GABA in the subthalamic nucleus in the choreic patients, although this did not reach significance. A differential loss of met-enkephalin in the globus pallidus externa compared with substance P loss in the globus pallidus interna was not observed in either the choreic patients with advanced disease or the grade II patients. There was a significant increase in GABA concentrations in the ventroanterior nucleus of the thalamus in the choreic patients compared with rigid/bradykinetic patients. These results are in accord with major tenets of proposed models of dyskinesia in experimental animals; however, the finding of increased GABA in the thalamus requires modification of current theories.
Received April 30, 1992. Revised April 22, 1993. Accepted May 6, 1993.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. K Magnet, R. M Bonelli, and H.-P. Kapfhammer Amantadine in the Akinetic-Rigid Variant of Huntington's Disease Ann. Pharmacother., July 1, 2004; 38(7): 1194 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Reuter, M T M Hu, T C Andrews, D J Brooks, C Clough, and K R. Chaudhuri Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome J. Neurol. Neurosurg. Psychiatry, February 1, 2000; 68(2): 238 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sanchez-Pernaute, G. Kunig, A. del Barrio Alba, J. G. de Yebenes, P. Vontobel, and K. L. Leenders Bradykinesia in early Huntington's disease Neurology, January 11, 2000; 54(1): 119 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J P P van Vugt, S Siesling, M Vergeer, E A van der Velde, and R A C Roos Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study J. Neurol. Neurosurg. Psychiatry, July 1, 1997; 63(1): 35 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Filloux Neuropathophysiology of Movement Disorders in Cerebral Palsy J Child Neurol, November 1, 1996; 11(1_suppl): S5 - S12. [Abstract] [PDF]
|
|